Thrilled to announce the next chapter of my academic journey! Honored to begin my postdoc as a Wallenberg fellow at @Stanford University, joining Dr. Bali Pulendran’s lab. Eager to contribute to the groundbreaking research happening here! @StanfordMed@KAWstiftelsen#Vaccinology
Two-layer defense system:
(1) Innate barrier blocks most pathogens at entry
(2) Anything that slips through faces "warp-speed" adaptive response in 3 days (vs. normal 2 weeks!)
Vaccinated mice stayed healthy while controls got severely sick. (6/8)
Results in mice: 3+ months protection against: SARS-CoV-2 & other coronaviruses, Staphylococcus aureus (hospital infections), Acinetobacter baumannii (drug-resistant bacteria), and House dust mite allergens.
700-1000x reduction in viral load! (5/8)
Check out our new review, "The lingering shadow of epidemics: post-acute sequelae across history" by Drs. Christine Miller and @jannamoen. We highlight historical accounts of post-acute infection syndromes (PAIS) through the centuries 👇🏼 #LongCOVID
https://t.co/gCS7nmVKUW
Our paper investigating EBV role in SLE is out in @ScienceTM@ScienceMagazine
For decades, Epstein–Barr Virus (EBV) has been associated with autoimmune diseases such as lupus (SLE), yet how this common virus contributes to autoimmunity has remained a mystery!
A groundbreaking paper by @younis_sh1 et al. @stanfordimmuno provides an answer to the long-standing question about how EBV infections are linked to lupus. A short thread to explain the key findings. (1/)
https://t.co/dUpz19IjEv
A new Review explores the mechanisms underlying inhibitory immune checkpoints and suggests that a deeper understanding of these nuances could improve checkpoint-based cancer #immunotherapies.
Learn more in Science #Immunology: https://t.co/5oF5YnWDKK
I am pleased to mention that our AI-driven multi-omics ME/CFS paper is now freely available in full text on PubMed. All data have also been deposited on GitHub.
https://t.co/cNBvqzHQqX
What I love about interferons is their simplicity ;-)
But seriously a great @CellCellPress new review of IFNs that are our 1st line of defense vs infections and critical for many inflammatory an autoimmune diseases. https://t.co/bgEfON1Rwi
New #breastmilk research from the @CHILDSTUDY: how a maternal antibody in milk prevents an allery-promoting microbe from colonizing the infant gut.
Exciting transnational work from @Kate_Donald_ & team!